Attenuated in vitro coronary arteriolar vasorelaxation to insulin-like growth factor I in experimental hypercholesterolemia

Hypertension

Volumn 34, Issue 1, 1999, Pages 89-95

  Hasdai, David ^a   Nielsen, Michael F ^a   Rizza, Robert A ^a   Holmes Jr , David R ^a   Richardson, Darcy M ^a   Cohen, Pinchas ^b   Lerman, Amir ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Arteries; Hypercholesterolemia; Insulin; Insulin growth factor; Pigs

Indexed keywords

CHOLESTEROL; ENDOTHELIN 1; INSULIN; N(G) NITROARGININE; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN C; TETRYLAMMONIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DILATATION; HYPERCHOLESTEROLEMIA; NONHUMAN; PRIORITY JOURNAL; SWINE;

EID: 0032792274     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.1.89     Document Type: Article

References (21)

1. Collett-Solberg PF, Cohen P. The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action. Endocrinol Metab Clin North Am. 1996;25:591-614.
2. Hansson HA, Jennische E, Skottner A. Regenerating endothelial cells express insulin-like growth factor-I immunoreactivity after arterial injury. Cell Tissue Res. 1987;250:499-505.
3. Khorsandi MJ, Fagin JA, Giannella-Neto D, Forrester JS, Cercek B. Regulation of insulin-like growth factor-I and its receptor in rat aorta after balloon denudation: evidence for local bioactivity. J Clin Invest. 1992;90: 1926-1931.
4. Hasdai D, Rizza RA, Holmes DR Jr, Richardson DM, Cohen P, Lerman A. Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitro. Hypertension. 1998;32:228-234.
5. Pete G, Dunbar JC. Regional blood flow dynamics in response to insulin and IGF-1 in diabetic animals. Clin Exp Hypertens. 1998;20:67-83.
6. Hasdai D, Sangiorgi G, Spagnoli LG, Simari RD, Holmes DR Jr, Kwon HM, Gregoire J, Carlson PJ, Schwartz RS, Lerman A. Coronary artery apoptosis in experimental hypercholesterolemia. Atherosclerosis. 1999;142:317-325.
7. Hasdai D, Mathew V, Schwartz RS, Smith LA, Holmes DR Jr, Katusic ZS, Lerman A. Enhanced endothelin-B-receptor-mediated vasoconstriction of small porcine coronary arteries in diet-induced hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1997;17:2737-2743.
8. Hasdai D, Mathew V, Schwartz RS, Holmes DR Jr, Lerman A. The effect of basic fibroblast growth factor on coronary vascular tone in experimental hypercholesterolemia in vivo and in vitro. Coron Artery Dis. 1997;8:299-304.
9. Mathew V, Cannan CR, Miller VM, Barber DA, Hasdai D, Schwartz RS, Holmes DR Jr, Lerman A. Enhanced endothelin mediated coronary vasoconstriction and attenuated basal nitric oxide activity in experimental hypercholesterolemia. Circulation. 1997;96:1930-1936.
10. Lerman A, Webster MWI, Chesebro JH, Edwards WD, Wei CM, Fuster V, Burnett JC Jr. Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs. Circulation. 1993;88:2923-2928.
11. Hasdai D, Best PJM, Cannan CR, Mathew V, Schwartz RS, Holmes DR Jr, Lerman A. Acute endothelin-receptor inhibition does not attenuate acetylcholine-induced coronary vasoconstriction in experimental hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1998;18:108-113.
12. Inishi Y, Okuda T, Arakawa T, Yasuda C, Ohara M, Kurokawa K. Insulin nonattenuation of vasoactive agent-induced responses in mesangial cells from spontaneously hypertensive rats. Kidney Int. 1995;47:891-898.
13. Inishi Y, Katoh T, Okuda T, Yamaguchi T, Kurokawa K. Modulation of renal hemodynamics by IGF-1 is absent in spontaneously hypertensive rats. Kidney Int. 1997;52:165-170.
14. Allain CC, Poon LS, Chan CSL, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470-475.
15. Gockerman A, Clemmons DR. Porcine aortic smooth muscle cells secrete a serine protease for insulin-like growth factor binding protein-2. Circ Res. 1995;76:514-521.
16. Cohick WS, Gockerman A, Clemmons DR. Regulation of insulin-like growth factor (IGF) binding protein-2 synthesis and degradation by platelet-derived growth factor and the IGFs is enhanced by serum deprivation in vascular smooth muscle cells. J Cell Physiol. 1995;164:187-196.
17. Feldman EL, Randolph AE. Regulation of insulin-like growth factor binding protein synthesis and secretion in human retinal pigment epithelial cells. J Cell Physiol. 1994;158:198-204.
18. Conover CA. A unique receptor-independent mechanism by which insulinlike growth factor I regulates the availability of insulin-like growth factor binding proteins in normal and transformed human fibroblasts. J Clin invest. 1991;88:1354-1361.
19. Kontos HA, Wei EP. Arginine analogues inhibit responses mediated by ATP-sensitive K+ channels. Am J Physiol. 1996;271:H1498-H1506.
20. Najibi S, Cowan CL, Palacino JJ, Cohen RA. Enhanced role of potassium channels in relaxation to acetylcholine in hypercholesterolemic rabbit carotid artery. Am J Physiol. 1994;266:H2061-H2067.
21. Grant MB, Wargovich TJ, Ellis EA, Caballero S, Mansour M, Pepine CJ. Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells: a potential treatment for restenosis? Circulation. 1994,89:1511-1517.